chrisvoncsefalvay/vaers-outcomes huggingface dataset:
First dose Moderna received on 3/10. On 3/15 I started feeling sick.  Extreme fatigue, chills and nausea. Over the next week my temperature was slightly elevated. 3/18 I went to clinic thinking this may be COVID.  Both rapid and regular tests came back negative.  The symptoms continued.  In addition I notice my resting heart rate (while I was in bed) was over 100 when it is normally <65.  (I am a runner and use a smart watch).  I went to my GP on 3/23  and the nurse practitioner ordered tests. COVID was negative.  C-Reactive Protein was 105. She sent me to the Cardiologist for suspected MyoCarditis. Cardiologist appt was 3/30/21.  Dr. planned to send me for an Echocardiogram but before this (continued)  was conducted, I started having chest pains and went to the emergency room. On 4/6-8/21 I was hospitalized.  A multitude of tests were performed. Chest Xray, Chest CT, Echocardiogram, MRI (which revealed scarring on one of the lower sections of my heart confirming the MyoCarditis), Hearth Catheterization. I was discharged 4/8/21.   I had a follow up Cardiologist Appt on 6/1/21.  I am ok'd to slowly start exercising again.  It has been hard to start running again so I am mostly walking 1-2 miles a day.  (previously I was logging 20 - 25 miles a week).    Question. My reaction was to the FIRST dose of Moderna.  I have not received the second dose.  Is there any data that shows the probability of a reaction to the second dose?  I want to be protected, but in addition to possible health concerns, the costs incurred from the hospitalization are a financial burden.
Severe grade 3 Headache, high fever, chills, grade 3lymphadenopathy, pain and swelling, high fever (grade 3) persisting several days, fatigue, lethargy, myalgia, arthralgia, grade 3 chills.
Swelling and rash at the site of injection on right deltoid region. Also mild rash/swelling below eyes on both cheeks.
Information has been received from a physician concerning a 12-month-old female who on 28-Oct-2005 was vaccinated in the right thigh with a dose of measles virus vaccine live plus mumps virus vaccine live plus rubella virus vaccine live plus varicella virus vaccine live. Concomitant vaccinations on the same day include a dose of hepatitis B virus vaccine rHBsAg (yeast) plus Hib conj vaccine (OMPC) and a dose of pneumococcal 4 6B 9V 18C 19F 23F conj vaccine (CRM197) (Prevnar). On 10-Nov-2005, the patient had a seizure at home. She was taken to the hospital and had two more seizures that same day in the emergency room. She was subsequently admitted to the hospital. There was no fever involved. A spinal tap showed no white cells so the physician ruled out aseptic meningitis. At the time of the report, the patient remained hospitalized. Additional information has been requested.
pt recv vax 1AUG96 & 6AUG96 pt devel diarrhea w/cramping;9AUG96 pt exp itching all over & devel a rash @ hairline, as well as gassiness;pt recovered from itching all over, rash & diarrhea w/cramping determined not likely r/t vax;
Throat got tight, did not need to take any medication, resolved on its own within 10 minutes, did not take 2nd dose and wondering if I have any protection from first dose.
This spontaneous report as received from a registered pharmacist refers to a 66-year-old-non-pregnant female patient with no known drug reactions or allergies. The patient's medical history was not reported. On an unknown date in October 2015, the patient was vaccinated with the first dose of PNEUMOVAX 23 injection (dose, route of administration, lot number and expiration date were not specified) and experienced no problems after receiving that dose. On 20-OCT-2016, the patient was vaccinated with the second dose of PNEUMOVAX 23 injection (lot# M036161, expiration date 06-MAY-2018; exact dose was not reported) intramuscularly in her right deltoid. Concomitant therapies included an unspecified influenza vaccine on an unknown date in September 2016, after which she experienced "no problem", SYNTHROID, amlodipine and unspecified eye drops. On 20-OCT-2016, 3 hours after the vaccination, the patient began experiencing difficulty raising the injection arm over her head with her elbow extended. The pharmacist reported that her injection site did not look red or swollen, but the patient was reporting weakness in the injection arm. The patient was monitored by the pharmacist at the time of this report. The reporter stated that the patient had never had any reaction to a vaccine. There was no treatment given for the events. No diagnostic lab studies were performed. The outcome of difficulty raising the injection arm over her head with her elbow extended and weakness in the injection arm was reported as not recovered/not resolved. The relatedness between the events and PNEUMOVAX 23 was not reported. Additional information has been requested.
Pfizer 3/15/21, 4/5/21, 11/19/21. Positive on 11/10/22
PROLONGED FEVERS >102°F DAILY FOR 4 DAYS FOLLOWING VACCINATION.  EXTREME FUSSINESS, DECREASED ORAL INTAKE.  NO EVIDENCE OF OTHER SYMPTOMS TO EXPLAIN FEVER & FUSSINESS.
Second dose of GARDASIL given to left deltoid muscle along with PPD to forearm.  About 5-10 min after shot, became pale fell forward, hit floor, 3 cm laceration to right eyebrow area.  Total time she was unconscious was less than one minute.
Muscle ache, headache, fatigue -- essentially severe flu-like symptoms beginning at approximately 10 hours after the injection and lasting for 10 hours.
Pain in arm spreading throughout first few hours, by 14 hours post vaccination hives began appearing with increased intensity and number. By 15 hours post vaccination a mild headache and low fever of 100.8 developed. Treatment included diphenhydramine to ease antihistamine response and aspirin to lower fever and reduce severity of headache.
Headache, Diarrhea, Palpitations, Tachycardia, Dizziness, as of 12/1/2021 reports sob worsening. Diagnosed with anemia 11/12/2021 Narrative:
sleepy and wanting to sleep all day; Chills; fever; weak; no appetite; fatigue; This is a spontaneous report from a contactable consumer (patient). A 79-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9267), via an unspecified route of administration, administered in right arm on 22Feb2021 12:00 (at the age of 79-years-old) as 1st dose, single for COVID-19 immunisation.  Medical history included high blood pressure, high cholesterol, acid reflux and shell fish allergy. The patient's concomitant medications were not reported. On 24Feb2021 at 12:00 chills, fever, no appetite, weak, fatigue, sleepy and wanting to sleep all day. The patient did not receive any treatment for the events. The patient did not have COVID prior vaccination. She was not COVID tested post vaccination. The outcome of events was recovering.   No follow-up attempts are possible. No further information is expected.
Right at one month from recieving the second dose I broke out in a skin rash that went from my hair line on the head cler to the top of my feet.  Everything was covered with the rash which was extremly painful.  the rash resembled small boils.  there was a boil roughly every 1/2".  I still have itchy skine and some small mole lokking spots have poped up on ny neck line.
PATIENT RECEIVED MORE THAN THE RECOMMENDED DOSES OF COVID-19 VACCINE. MODERNA WAS ADMINISTERED THREE TIMES 3/29/2021, 4/26/2021, AND 8/2/2021. PFIZER ADMINISTERED TWICE 4/15/2021 AND 5/6/2021. JANSSEN ADMINISTERED ONCE ON 5/25/2021.
Throat swelling, tongue numb, wheezing, coughing, runny eyes approximately 3 hours after receiving flu vaccine.
CHILD AGED 7 RECEIVED ADULT LOT # AND DOSE OF PFIZER AS SECOND DOSE
Headache, Myalgia,  NUMBNESS OF HANDS AND FEET LASTING  SEVERAL DAYS
Pt passed out in observation. Rolled pt to EMS area. Pt woke up. Pt pulse rate 46. Pt started throwing up and was sweating. Pt started feeling better.  When EMS services came they assessed and pt was fine.
Fever of 102 F, body tremors, fatigue, muscle ache, trouble walking, (stiffness)
Lightheadedness and headache about 8 hours after vaccination, restless sleep during the night. Next morning before taking a shower felt lightheaded and sick to stomach. After my shower I fainted and  had an ankle contusion due to fall.
pt recv vax; inc T of 104R; high pitched cry; MD states child did not sleep nl or act nl for 4-5 days p/ vax;less smiling for 4-5 days;pt went back to nl routine;
First Dose: No arm soreness, but...extreme muscle, joint, neck, throat, headache, screaming ear noise, and body tension, and very sick...8 DAYS following the first injection. No fever, and vitals were OK. 800 mg Ibuprofen and Norco did not ease the pain. It was unbearable. Was tested for Covid and Strep, and both came back negative. I called my Primary Care physician and the local ER. All they said to do was to hydrate. Went to urgent cacre...no help. Lingering fatigue for another week. Finally after two weeks, the symptoms subsided. Second Dose. Same kind of pain on second day, but seems to be subsiding...so far. But, my injection site is very sore, swollen, and red. Does not seem to be getting better 5 days out.
This spontaneous report was received from a healthcare worker refers to a patient of unknown demography. On an unknown date, unspecified number of patients were vaccinated with M-M-R II (dose, route and frequency were not reported) for which no recorded temperatures for four months. No adverse effects were reported. No further information was provided. This case is linked to the case 1404USA006470 and 1404USA007005 (same reporter link). Additional information has been requested.
6 days, post vax, pt complained of fatigue, headache and day 7 pt had chills (didn't check temperature). Saturday, temperature 99.2F and continued with headaches. Sunday, temperature was 101F. Taking Tylenol #3 with some relief. Today still with severe headaches but refusing to go see MD; says will see MD if fever returns. (Temperature, 1 day post vax X 1 day. Feels not related to vaccine).
Lip Tingling. Pt c/o lip tingling post covid vaccination. RN assessed pt, pt AOx4 breathing even and unlabored, not in any form of distress, no evidence of swelling/redness around mouth area. Pt denies CP, palpitation, SOB, difficulty breathing, sore throat or throat tightness.  Reported to Dr., per Dr.'s recommendation to give ER precaution for any worsening, alarming symptoms. Pt was in clinic for more than 30 minutes post covid vaccination for observation; no other symptoms noted. @2:20 pm pt denies tingling in lips and states symptoms went away. ER/911 precaution given to pt for difficulty breathing, CP, palpitation, throat tightness, any worsening alarming condition. Pt agrees and verbalized understandi
Suspect measles rash confluent red papular patches to torso also has on Dorsal feet, hands only a few to palms soles. no oral lesions face is mostly spared. has about the ears also
the lymph nodes under armpit on the injection arm were sore; fatigued; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE LYMPHADENOPATHY (the lymph nodes under armpit on the injection arm were sore) and FATIGUE (fatigued) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0219B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported.).    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (the lymph nodes under armpit on the injection arm were sore) and FATIGUE (fatigued). At the time of the report, VACCINATION SITE LYMPHADENOPATHY (the lymph nodes under armpit on the injection arm were sore) and FATIGUE (fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Moderna Dose 1 6/4/21 (035C21A) Moderna Dose 2 7/2/21 (NA) COVID Positive 2/5/21 COVID Positive 2/8/21  2/8/22: Patient is a 82 year-old female patient with a past medical history of COPD (on home O2 2L),  presented to hospital with complaints of shortness of breath that progressively became worse with ambulation for the last couple days. Symptoms associated with non-productive cough, sore throat and low grade fever 99F. She was recently seen at urgent care for increased cough and was prescribed antibiotic and steroid. Patient reports that she did not feel improvement in her symptoms. Pt had 2 vaccinations for COVID 19, no booster yet.  On admission to ED pt's BP 141/74, RR 20, HR 97, pulse ox 100% on 2 L nasal cannula. Laboratory findings showed leukocytosis WBC 14.88,  Creatinine 1.09, BUN 30, blood gases with pCO2 57, pro BNP 1480, d-dimer 1.4 . CT chest angiogram negative for PE, show bilateral mild ground-glass opacity, basal consolidation.   Pt was seen and evaluated at bedside. On supplemental oxygen 2L saturating 99%. She denies any chest pain, dizziness or lightheadedness, denies nausea, vomiting, problems with urination no diarrhea.  2/9/22: The patient known to have COPD on 2 L of oxygen at home, diagnosed with COVID-19 infection 5 days ago and her symptoms worse about 7 days ago, she is vaccinated but she did not get her booster, presented with worsen shortness of breath and cough and increased oxygen requirement initially at ED to 4 L, initially had bilateral wheezing and crepitation which improved after IV steroids and antibiotic and schedule nebulizer treatment and inhalers.  Her chest CT angiogram negative for PE.  The patient continue on schedule IV steroid with inhalers and antibiotic with faster than expected improvement in her symptoms and her oxygen requirement back to its baseline 2 L through nasal cannula and no more wheezing or shortness of breath and she has been able to ambulate independently.  Discussed with the patient, will discharge her home on inhaler and prednisone with COVID-19 safe home program.
arm pain, runny nose, extreme fatigue, fever highest 101.5 .symptoms resolved after 2 days. took over the counter analgesic
12/1/16: about 5pm - hives started; 5:30pm - hives spread to most of upper body (including ears and scalp), started to get GI issues; 7:00pm hives on entire body, severe GI issues with simultaneous vomiting and diarrhea; 12/2/16: approximately 2:00am symptoms were gone, left feeling only fatigue.
13-year old patient was given heplisav-b, which is licensed for adults only.
patient previously had Pfizer vaccine and requested Pfizer booster but was given Moderna booster. patient was informed ,vaccine card corrected and correct information reported to registry
Initial information received on 02-Nov-2018 regarding an unsolicited valid non-serious case received from a nurse. This case involves a six years old male patient who experienced arm swelling, malaise and headache, while he received vaccine QUADRACEL. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a third dose of 0.5 ml suspect DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE (frequency once) lot C5325BA, expiry date: 14-Nov-2019 via intramuscular route in the right arm. On an unknown date, the patient developed a non-serious arm swelling, malaise and headache (Unknown latency) following the administration of DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE. It was reported that the patient visited to physician on 02-Oct-2018. (Other relevant tests included No lab data.) Final diagnosis was headache, malaise and arm swelling. No corrective treatment was received. On an unknown date, the patient was recovered from the events. List of documents held by sender: none.
Patient started started having tongue was tingling and started to move down her throat. Continued to monitor patient, patient later stated she could feell her throat closing but was not having trouble breathing, patient also started to fan herself. Ambulance was then called and patient help in ambulance while still conscious.
chills, fever, body aches, exhaustion from 1 am 2/17/21 (morning after shot) to approx 1 pm 2/18/21. By 6 pm 2/18/21 right arm by injection site was yellow in a one inch circle and raised with red hot skin radiating about 3 inches in every direction out from that inner circle. Injection site responded well to ice pack. Same irritation but much less red.
This spontaneous report was received from a registered nurse regarding a 68 year old patient of unknown gender. Information on patient's pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On 06-MAR-2018, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 lot # N030111, expiration date 21-APR-2019 (dose, route of administration were not reported), (strength and dose were not reported) orally for prophylaxis. It was reported that the vaccine was stored between 0 degrees Celsius to 1 degrees Celsius (0.4 C) for 30 minutes. Previous cold temperature excursion (09-FEB-2018) was from 0 degrees Celsius to 1 degrees Celsius (0.9 C) for 40 minutes. The digital data logger was involved in recording the temperature excursion. No adverse effects were reported. There was no product quality complaint (PQC) reported. This is one of the multiple reports received from the same Reporter. Sender's Comments: US-009507513-1809USA008676: US-009507513-1803USA009994: US-009507513-1809USA008678: US-009507513-1809USA008679: US-009507513-1809USA008678.
Information has been received from a registered nurse referring to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 23-JUL-2015 the patient was vaccinated with a dose of M-M-R II (lot #, expiration date, route and dose were unknown) and a dose of PROQUAD (Merck) (lot #, expiration date, route and dose were unknown) (overdose). No adverse experience reported. There were no product quality complaints (PQC) involved. Additional information has been requested.
I received my vaccine and within minutes I felt unwell. My whole face flushed and hives, throat was itchy and felt bigger, runny nose, eyes watering and lightheadedness. I had an extremely high blood pressure, and I was unable to use my EPIPEN. The hospital and pharmacy were close to each other. I went to the emergency room for observation for the whole day. I had symptoms for over a month after that. My allergist said I should have used the EPIPEN anyway.
HUGE welt on my arm, the size of the opening of a solo cup.  Very red and puffy. VERY sore. Nauseous and dizzy.  Marked it on 11/5 and it has gotten bigger since.
Rashes over face, injection site 128/68, 100, 97, 100% H. Pt. alert and oriented X3.  Rashes observed to injection site.  Per EMS pt. will be transferred to Plantation for further evaluation.
A report has been received from a Health Professional concerning a 2 year old, male subject, who had been receiving nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 12-Dec-2013. It was reported that forty two patients were administered with expired FLUMIST QUADRIVALENT (Preferred Term: Expired drug administered) which started on 12-Dec-2013. The outcome of the event of gave expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
HPI: Patient is a * year old * who presents following administration of the first dose of the COVID19 vaccine in the left deltoid.  Patient has a history of vasovagal syncope/reaction and was not conscious upon medical response arrival.  No head trauma.  Patient denies allergies.  Patient denies past medical history.  Patient only taking a low dose combination OCP.  She states she has only eaten breakfast.  She otherwise denies chest pain, difficulty breathing, swelling of the face/lips/tongue/throat, skin rash/itching, cramping abdominal pain, nausea, and vomiting.     Exam (update as needed): GEN: Patient not conscious upon arrival.  Upon reclining patient and elevating legs, patient alert & oriented x 4.  NAD HEAD: NCAT EYES: PERRL, EOMI upon intervention. ENT: Ears normal, Nose normal, OP normal, no evidence of angioedema NECK: Supple, without LAD.  CV: Weak, thready radial pulse.  RRR, no m/r/g PULM: Clear to auscultation bilaterally, no accessory muscle use ABD: Soft, no tenderness. SKIN: No rashes, skin warm and dry.  No erythema or edema of the injection site. MSK: FROM, MS 5/5 NEURO: Upon intervention, patient alert & oriented x 4.  CN 2-12 grossly intact, no ataxia, gait steady   Clinical Impression/Field Tx: Vasovagal syncope.  Upon reclining patient and elevating the legs, patient regained consciousness and was A&O x 4.  EMS called to the scene for further evaluation, to include EKG.  Patient not actively displaying signs or symptoms of anaphylaxis.  Vital signs stable upon transfer of care.   Instructed patient to consult their PCP regarding the post-vaccination reaction.  Patient instructed to go to emergency department should they develop chest pain, difficulty breathing, swelling of the face/lips/mouth/tongue/throat, or cramping abdominal pain with nausea/vomiting, as these are signs of possible anaphylaxis that requires immediate intervention.     Medications administered: None   Disposition:   EMS was called to the site for further evaluation.  Patient elected to not transport to the hospital and left with her parents.
booster; The redness has grown in the course of the last five days; When I received the vaccination I had a modest lump and little bit of redness; This is a spontaneous report from a contactable consumer. A 73-year-old female patient received third dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 04Oct2021 (Batch/Lot Number: 30145BA) (at the age of 73-year-old) as dose 3 (booster), single for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included hydrochlorothiazide, potassium, acetylsalicylic acid (BABY ASPIRIN), vitamin D3 and Gummy vitamins. The patient received first and second dose of BNT162B2 on unknown date for covid-19 immunization. On 04Oct2021 the patient experienced booster. On an unknown date in Oct2021 the patient experienced The redness has grown in the course of the last five days and When I received the vaccination I had a modest lump and little bit of redness. Therapeutic measures were taken as a result of The redness has grown in the course of the last five days and When I received the vaccination I had a modest lump and little bit of redness. The patient reported that she received two Pfizer vaccinations (Covid-19 Vaccine) and this week on Monday got the booster and had a question regarding the side effects. When she received the vaccination she had a modest lump and little bit of redness but this is Friday , she got the vaccination on Monday, today is Friday and the red area has grown considerably. It was modest, the average size. The redness has grown in the course of the last five days. She asked if that was okay and was it supposed to grow in size or supposed to get smaller. She took one Tylenol. She stated that she should be concerned about her arm getting red. She was advised to consult with her healthcare provider. The outcome of the event The redness has grown in the course of the last five days was not resolved, for the event When I received the vaccination I had a modest lump and little bit of redness the outcome was unknown. Follow-up attempts completed. No further information expected.